PP_1170x120_10-25-21

Acular Ophthalmic Solution

Aurobindo gets FDA approval for ketorolac tromethamine ophthalmic solution, 0.5%.

Aurobindo gets FDA approval for ketorolac tromethamine ophthalmic solution, 0.5%.

EAST WINDSOR, N.J. – Aurobindo Pharma has received final approval from U.S. Food and Drug Administration for its Abbreviated New Drug Application ketorolac tromethamine ophthalmic solution, 0.5%. Aurobindo Pharma’s ketorolac tromethamine ophthalmic solution, 0.5% are an AB-rated generic equivalent to the reference listed drug (RLD), Acular Ophthalmic Solution, 0.5% (Allergan, Inc.) Ketorolac tromethamine ophthalmic solution